These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9840623)
21. Prevention of osteoporosis and fractures. Ullom-Minnich P Am Fam Physician; 1999 Jul; 60(1):194-202. PubMed ID: 10414638 [TBL] [Abstract][Full Text] [Related]
22. [Osteoporosis. Bone mass, fractures, treatment and compliance]. Høiseth A Tidsskr Nor Laegeforen; 1997 Sep; 117(22):3188-90. PubMed ID: 9411854 [TBL] [Abstract][Full Text] [Related]
23. ["European Guidance 2008" for the diagnosis and management of postmenopausal osteoporosis--what is new and clinically relevant?]. Bartl R; Dtsch Med Wochenschr; 2009 Jan; 134(3):92-4. PubMed ID: 19142840 [No Abstract] [Full Text] [Related]
24. Practical issues in bone mineral density testing. Simonelli C J Am Med Womens Assoc (1972); 2000; 55(4):228-33. PubMed ID: 10935358 [TBL] [Abstract][Full Text] [Related]
25. [Prevention of osteoporotic fractures]. Kannus P Duodecim; 1999; 115(7):759-64. PubMed ID: 11859509 [No Abstract] [Full Text] [Related]
26. Risk factors and prevention of osteoporosis-related fractures. Dontas IA; Yiannakopoulos CK J Musculoskelet Neuronal Interact; 2007; 7(3):268-72. PubMed ID: 17947811 [TBL] [Abstract][Full Text] [Related]
27. Summaries for patients. Screening for osteoporosis: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med; 2002 Sep; 137(6):I59. PubMed ID: 12230384 [No Abstract] [Full Text] [Related]
28. [Bones are breaking without estrogen]. Komulainen M; Tuppurainen M; Kröger H Duodecim; 2003; 119(22):2183-9. PubMed ID: 14702807 [No Abstract] [Full Text] [Related]
30. Assessment of the risk of osteoporosis at the menopause: therapeutic consequences. Raisz LG Osteoporos Int; 1994; 4 Suppl 1():53-7. PubMed ID: 8081061 [TBL] [Abstract][Full Text] [Related]
31. [The Medical Products Agency on prevention of osteoporosis: estrogen reduces the risk of fractures in certain women]. Lakartidningen; 1994 Jan; 91(1-2):58-60. PubMed ID: 8289556 [No Abstract] [Full Text] [Related]
33. Osteoporosis and fracture risk assessment: improving outcomes in postmenopausal women. Perez MO; Pedro PPA; Lyrio AM; Grizzo FMF; Loures MAADR Rev Assoc Med Bras (1992); 2023; 69(suppl 1):e2023S130. PubMed ID: 37556649 [No Abstract] [Full Text] [Related]
34. Prevention for the older woman. A practical guide to prevention and treatment of osteoporosis. Messinger-Rapport BJ; Thacker HL Geriatrics; 2002 Apr; 57(4):16-8, 21-4, 27. PubMed ID: 11974387 [TBL] [Abstract][Full Text] [Related]
35. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)? Sambrook P Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):975-81. PubMed ID: 16301191 [TBL] [Abstract][Full Text] [Related]
37. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894 [TBL] [Abstract][Full Text] [Related]
39. [The diagnosis of osteoporosis]. Fukunaga M; Nagai K Clin Calcium; 2005 Apr; 15(4):569-75. PubMed ID: 15802767 [TBL] [Abstract][Full Text] [Related]
40. The role of clinical assessment in the prevention of osteoporotic fractures. Hough S S Afr Med J; 2000 Nov; 90(11):1109-11. PubMed ID: 11196028 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]